1. Home
  2. ZURA vs NAUT Comparison

ZURA vs NAUT Comparison

Compare ZURA & NAUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZURA
  • NAUT
  • Stock Information
  • Founded
  • ZURA 2022
  • NAUT 2016
  • Country
  • ZURA United States
  • NAUT United States
  • Employees
  • ZURA N/A
  • NAUT N/A
  • Industry
  • ZURA Biotechnology: Biological Products (No Diagnostic Substances)
  • NAUT Biotechnology: Laboratory Analytical Instruments
  • Sector
  • ZURA Health Care
  • NAUT Industrials
  • Exchange
  • ZURA Nasdaq
  • NAUT Nasdaq
  • Market Cap
  • ZURA 292.1M
  • NAUT 284.7M
  • IPO Year
  • ZURA N/A
  • NAUT N/A
  • Fundamental
  • Price
  • ZURA $2.88
  • NAUT $2.14
  • Analyst Decision
  • ZURA Buy
  • NAUT Hold
  • Analyst Count
  • ZURA 6
  • NAUT 3
  • Target Price
  • ZURA $15.80
  • NAUT $3.58
  • AVG Volume (30 Days)
  • ZURA 390.6K
  • NAUT 154.4K
  • Earning Date
  • ZURA 11-07-2024
  • NAUT 10-29-2024
  • Dividend Yield
  • ZURA N/A
  • NAUT N/A
  • EPS Growth
  • ZURA N/A
  • NAUT N/A
  • EPS
  • ZURA N/A
  • NAUT N/A
  • Revenue
  • ZURA N/A
  • NAUT N/A
  • Revenue This Year
  • ZURA N/A
  • NAUT N/A
  • Revenue Next Year
  • ZURA N/A
  • NAUT N/A
  • P/E Ratio
  • ZURA N/A
  • NAUT N/A
  • Revenue Growth
  • ZURA N/A
  • NAUT N/A
  • 52 Week Low
  • ZURA $2.00
  • NAUT $1.88
  • 52 Week High
  • ZURA $6.35
  • NAUT $3.46
  • Technical
  • Relative Strength Index (RSI)
  • ZURA 36.44
  • NAUT 41.16
  • Support Level
  • ZURA $2.71
  • NAUT $1.88
  • Resistance Level
  • ZURA $2.87
  • NAUT $2.26
  • Average True Range (ATR)
  • ZURA 0.23
  • NAUT 0.16
  • MACD
  • ZURA -0.01
  • NAUT -0.02
  • Stochastic Oscillator
  • ZURA 31.51
  • NAUT 41.73

About ZURA Zura Bio Limited

Zura Bio Ltd is a multi-asset clinical-stage biotechnology company focused on developing novel medicines for immune and inflammatory disorders.

About NAUT Nautilus Biotechnolgy Inc.

Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. It has built a prototype of a single-molecule instrument, Proteomic Analysis System.

Share on Social Networks: